FCA, d. M., LHRM, R., RMR, B., & MH, H. (2026). Leukotriene receptor antagonist drugs as potential chemopreventive agents: A systematic review and meta-analysis of cancer risk in asthmatic patients. Prostaglandins, leukotrienes, and essential fatty acids, 209, 102732. https://doi.org/10.1016/j.plefa.2026.102732
Chicago Style (17th ed.) CitationFCA, de Moraes, Rego LHRM, Burbano RMR, and Hirata MH. "Leukotriene Receptor Antagonist Drugs as Potential Chemopreventive Agents: A Systematic Review and Meta-analysis of Cancer Risk in Asthmatic Patients." Prostaglandins, Leukotrienes, and Essential Fatty Acids 209 (2026): 102732. https://doi.org/10.1016/j.plefa.2026.102732.
MLA (9th ed.) CitationFCA, de Moraes, et al. "Leukotriene Receptor Antagonist Drugs as Potential Chemopreventive Agents: A Systematic Review and Meta-analysis of Cancer Risk in Asthmatic Patients." Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 209, 2026, p. 102732, https://doi.org/10.1016/j.plefa.2026.102732.